Showing results (281-290 of 291) with videos related to
Sort By:
Pageof 30
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2001
Fluorouracil modulation in colorectal cancer: lack of improvement with N -phosphonoacetyl- l -aspartic acid or oral leucovorin or interferon, but enhanced therapeutic index with weekly 24-hour infusion schedule--an Eastern Cooperative Oncology Group/Cancer and Leukemia Group B StudyP J O'Dwyer, J Manola, F H Valone, et al.The American Journal of Medicine|March 1, 1980
High dose methotrexate with leucovorin rescue. Rationale and spectrum of antitumor activityE Frei, R H Blum, S W Pitman, et al.Cancer Research|September 29, 1998
Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtypeC D Bloomfield, D Lawrence, J C Byrd, et al.Blood|December 31, 1997
Adult patients with de novo acute myeloid leukemia and t(9; 11)(p22; q23) have a superior outcome to patients with other translocations involving band 11q23: a cancer and leukemia group B studyK Mrózek, K Heinonen, D Lawrence, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Secondary cytogenetic changes in acute promyelocytic leukemia--prognostic importance in patients treated with chemotherapy alone and association with the intron 3 breakpoint of the PML gene: a Cancer and Leukemia Group B studyJ L Slack, D C Arthur, D Lawrence, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 14, 2009
Weekly docetaxel, cisplatin, and irinotecan (TPC): results of a multicenter phase II trial in patients with metastatic esophagogastric cancerP C Enzinger, D P Ryan, J W Clark, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461J C Byrd, R B Weiss, D C Arthur, et al.European Journal of Immunology|February 17, 1998
IgE secretion is attenuated by an inhibitor of proteolytic processing of CD23 (Fc epsilonRII)G Christie, A Barton, B Bolognese, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 1998
Comparison of psychosocial adaptation of advanced stage Hodgkin's disease and acute leukemia survivors. Cancer and Leukemia Group BA B Kornblith, J E Herndon, E Zuckerman, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2017
Predicted vitamin D status and colon cancer recurrence and mortality in CALGB 89803 (Alliance)M A Fuchs, C Yuan, K Sato, et al.Pageof 30